Vivani Medical Expects Cortigent-ClearOne Merger to Close in October 2026

Key Facts

1Vivani Medical expects the merger of its subsidiary Cortigent with ClearOne to close in October 2026.

2Vivani Medical will receive 12,500,000 shares of ClearOne common stock as part of the merger.

In a move reflecting a strategic divestment to unlock equity value, Vivani Medical announced it expects the merger of its subsidiary Cortigent with ClearOne to close in October 2026. Upon completion, Cortigent will become a wholly owned subsidiary of ClearOne. According to reports, Vivani Medical is slated to receive 12,500,000 shares of ClearOne common stock as part of the transaction.

This development comes as the involved entities maintain steady market positions. Per market data, ClearOne (CLRO) shares closed at $4.19 on September 16, 2026, while Vivani Medical (VANI) shares stood at $1.22 on the same date. The transaction represents a significant shift in Vivani's asset portfolio, exchanging direct subsidiary control for a substantial equity stake in ClearOne.

Traders are monitoring price action as the October deadline approaches. CLRO reached a day high of $4.58 as of the September 16, 2026 close, providing a key level for market participants to watch. With no immediate sector-specific catalysts in the upcoming economic calendar, investor focus remains squarely on the final execution of the merger agreement.